ArticlePloS one2020

Preliminary validation of the use of IgG antibody response to Anopheles gSG6-p1 salivary peptide to assess human exposure to malaria vector bites in two endemic areas of Cameroon in Central Africa.

Glwadys Cheteug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.